Effect of curcumin on ulcerative colitis
Phase 3
- Conditions
- lcerative colitis.ulcerative colitis
- Registration Number
- IRCT2017052634142N1
- Lead Sponsor
- Deputy of Research and Technology, Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Patients 18-80 years old with mild to moderate ulcerative colitis based on Simple Clinical Colitis Activity Index
Exclusion criteria: hospital admission; significant comorbidities including liver or kidney diseases; pregnancy; lactating women; significant side effects during the intervention
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of ulcerative colitis. Timepoint: Before the intervention, two weeks and four weeks after the intervention onset. Method of measurement: Based on Simple Clinical Colitis Activity Index.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: Two weeks and four weeks after the intervention onset and also any time patient reports during the intervention. Method of measurement: Interviews with patients.